NCT07490132|Recruiting
Loading search results
Sponsor study identifier
observational
100
1 country
1
Study Start
February 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
February 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
February 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 18, 2026
Actual (reported)March 24, 2026
Actual (reported)February 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
February 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Underwent ERCP
Patients undergoing ERCPs at Methodist Dallas Medical Center.
25 years
Underwent ERCP between January 1, 2000 through December 31, 2025
The registry will include all patients who meet registry inclusion. Enrollment will terminate once 25 years of data are captured: January 1, 2000 through December 31, 2025.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients who underwent ERCP and in MDI(Methodist Digestive Institute) registry.
Methodist Dallas Medical Center- Clinical Research Institute
Dallas, Texas, 75203, United States
Prashant Kedia, MD
Methodist Health System
First Submitted
March 18, 2026
First Posted
March 24, 2026
Study Start
February 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
February 2027
Evaluation of the Impact of a Forward Viewing Scope at Time of ERCP
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
February 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
March 24, 2026
Record last verified: 2026-02
The investigator will make all possible efforts to ensure compliance with all policies regarding sharing of Protected Health Information or research information. Only de-identified Protected Health Information will be shared in relevant research mediums.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: